Company / Current Assets
Verrica Pharmaceuticals Inc. Current Assets History
FY2021-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Current Assets
$42.5M
FY2025
5-year range
$39.1M / $77.5M
FY2021-FY2025
Trend
-16.9%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Declined from $78M to $43M over the past 2 years.
Based on SEC 10-K filings.
$43M in FY2025 with a 3-year CAGR of +2.8%.
Declined from $78M to $43M over the past 2 years.
Current Assets over time
Growth rates
- 3-Year CAGR
- +2.8%
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- 3-year CAGR of +2.8%, indicating consistent growth.
- In FY2025, current assets decreased 16.9% year-over-year.
- Peak current assets was recorded in FY2023.
- Lowest current assets in the period was in FY2022.
Company context
Key Data Points
- Altman Z-Score -3.86 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Current AssetsValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $42.5M | -16.9% |
| FY2024 | $51.2M | -34.0% |
| FY2023 | $77.5M | +98.2% |
| FY2022 | $39.1M | -47.4% |
| FY2021 | $74.3M | - |
As of FY2025 · SEC 10-K · Updated Jun 28, 2026